-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q/tO6kUC+wYdZsk5DJuZU6P+WZ+Vd+BIpqSst+M3BRfvbuyfM9U8egoZOTROrVb4 hQmTwV4Z74CCOCq0W48/zQ== 0000891618-00-001446.txt : 20000316 0000891618-00-001446.hdr.sgml : 20000316 ACCESSION NUMBER: 0000891618-00-001446 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PAIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001069530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911911336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: SEC FILE NUMBER: 000-29959 FILM NUMBER: 569508 BUSINESS ADDRESS: STREET 1: 250 EAST GRAND AVENUE STREET 2: SUITE 70 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6506248200 MAIL ADDRESS: STREET 1: 250 EAST GRAND AVENUE STREET 2: SUITE 70 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-A12G 1 FORM 8-A 1 FORM 8-A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 Pain Therapeutics, Inc. (Exact name of Registrant as specified in its charter) Delaware 91-1911336 - ---------------------------------------- ------------------------------------ (State of Incorporation or organization) (I.R.S. Employer Identification No.) 250 East Grand Avenue, Suite 70, South San Francisco, California 94080 - ---------------------------------------------------------------- ---------- (Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act: NONE - -------------------------------------------------------------------------------- Securities to be registered pursuant to Section 12(g) of the Act: COMMON STOCK, $0.001 PAR VALUE - -------------------------------------------------------------------------------- 2 Item 1. Description of Registrant's Securities to be Registered. Incorporated by reference to Description of Capital Stock section and Shares Eligible for Future Sales sections on pages 54 to 59 of the Registrant's Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 14, 2000, as amended (file number 333-32370) (the "S-1 Registration Statement"). Item 2. Exhibits. The following exhibit is filed as a part of this Registration Statement: *1.1 Specimen of Registrant's Common Stock Certificate. *2.1 Form of Amended and Restated Certificate of Incorporation of Registrant to be filed with the Secretary of State of Delaware upon closing of the Registrant's initial public offering. *2.2 Form of Amended and Restated By Laws of Registrant to be in effect upon closing of Registrant's initial public offering. *2.3 Second Amended and Restated Investors' Rights Agreement dated February 1, 2000 between Registrant and the holders of its Series B and C redeemable convertible preferred stock.
* Incorporated by reference to the Exhibits to the S-1 Registration Statement. -2- 3 SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized. Dated: March 14, 2000 Pain Therapeutics, Inc. By: /s/ REMI BARBIER ------------------------------------- Remi Barbier, President, Chief Executive Officer And Chairman
-----END PRIVACY-ENHANCED MESSAGE-----